MedPath

Effect of single dose Phenobarbital on treatment of term and near term newborn'shyper bilirubinemia admitted in the hospital

Phase 2
Conditions
ear term newborn's hyper bilirubinemia.
Neonatal jaundice, unspecified
Registration Number
IRCT2014102919716N4
Lead Sponsor
orth Khorasan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Term and near-term babies (> 35 week) or (> 2500 g) with serum bilirubin levels in the therapeutic range (> 15 mg / dl) who admitted in hospital without signs of hemolysis, internal bleeding, G6PD, sepsis, severe respiratory illness requiring mechanical ventilation and congenital anomalies are enrolled after parental consent.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum bilirubin. Timepoint: Weeks 35-42. Method of measurement: Blood sample test.;Hematocrit,coombs,blood group,retic count. Timepoint: at birth time and starting treatment to discharge at hospital. Method of measurement: serum examination.
Secondary Outcome Measures
NameTimeMethod
Hospitalization period, phototherapy duration. Timepoint: Days of hospitalization, hours of phototherapy. Method of measurement: Medical records.
© Copyright 2025. All Rights Reserved by MedPath